HCB-101(hC Bioscience)

N/A

Report date: 2024/05/24 09:41:30

Base Information

Drug NameHCB-101(hC Bioscience)
Drug Alias NameHCB 101(hC Bioscience)HCB-101HCB 101
ClassificationCell and gene therapy > Gene therapy > tRNA
Mechanisms of ActionCoagulation factor VIII replacements
TargetsCoagulation factor VIII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHC Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesHC Bioscience Inc
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A